Estrogen receptor-β messenger RNA expression in human breast tumor biopsies: Relationship to steroid receptor status and regulation by progestins

Cancer Research

Volumn 59, Issue 3, 1999, Pages 529-532

  Dotzlaw, Helmut ^a   Leygue, Etienne ^a   Watson, Peter H ^a   Murphy, Leigh C ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GESTAGEN; MESSENGER RNA;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOPSY; BREAST NEOPLASMS; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; PROGESTINS; PROTEIN ISOFORMS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033083821     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kuiper, G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA, 93: 5925-5930, 1996.
2. Mosselman, S., Polman, J., and Dijkema, R. ER-β: identification and characterization of a novel human estrogen receptor. FEBS Lett., 392: 49-53, 1996.
3. Tremblay, G., Tremblay, A., Copeland, N., Gilbert, D., Jenkins, N., Labrie, F., and Giguere, V. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol. Endocrinol., 11: 353-365, 1997.
4. Dotzlaw, H., Leygue, E., Watson, P., and Murphy, L. Expression of estrogen receptor-β in human breast tumors. J. Clin. Endocrinol. Metab., 82: 2371-2374, 1997.
5. Lu, B., Leygue, E., Dotzlaw, H., Murphy, L. J., Murphy, L. C., and Watson, P. H. Estrogen receptor-β mRNA variants in human and murine tissues. Mol. Cell. Endocrinol., 138: 199-203, 1998.
6. Leygue, E., Dotzlaw, H., Watson, P., and Murphy, L. Altered estrogen receptor a and β mRNA expression during human breast tumorigenesis. Cancer Res., 58: 3197-3201, 1998.
7. Alkhalaf, M., and Murphy, L. C. Regulation of c-jun and jun-B by progestins in T-47D human breast cancer cells. Mol. Endocrinol., 6: 1625-1633, 1992.
8. Enmark, E., Pelto-Huikko, M., Grandien, K., Lagercrantz, S., Lagercrantz, J., Fried, G., Nordenskjold, M., and Gustafsson, J-A. Human estrogen receptor β gene structure, chromosomal localization and expression pattern. J. Clin. Endocrinol. Metab., 82: 4258-4265, 1997.
9. Vladusic, E., Homby, A., Guerra-Vladusic, F., and Lupu, R. Expression of estrogen receptor β messenger RNA variant in breast cancer. Cancer Res., 58: 210-214, 1998.
10. Moore, J., McKee, D., Slentz-Kesler, K., Moore, L., Jones, S., Home, E., Su, J-L., Kliewer, S., Lehmann, J., and Wilson, T. Cloning and characterization of human estrogen receptor β isoforms. Biochem. Biophys. Res. Commun., 247: 75-78, 1998.
11. Ravdin, P., Green, S., Dorr, T., McGuire, W., Fabian, C., Pugh, R., Carter, R., Rivkin, S., Borst, J., Belt, R., Metch, B., and Osborne, C. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. J. Clin. Oncol., 10: 1284-1291, 1992.
12. Paech, K., Webb, P., Kuiper, G., Nilsson, S., Gustafssoll, J., angst, Kushner, P. J., and Scanlan, T. S. Differential ligand activation of estrogen receptors ERα and ERβ at API sites. Science (Washington DC) 277: 1508-1510, 1997.
13. Read, L., Greene, G., and Katzenellenbogen, B. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists and growth factors. Mol. Endocrinol., 3: 295-304, 1989.
14. McClelland, R., Berger, U., Miller, L., Powles, T., and Coombes, R. Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to biochemical assay and outcome of therapy. J. Clin. Oncol., 4: 1171-1176, 1986.
15. May, E., Mouriesse, H., May-Leven, F., Contesso, G., and Delarue, J. A new approach allowing an early prognosis in breast cancer: the ratio of estrogen receptor (ER) ligand binding activity to the ER-specific mRNA level. Oncogene, 4: 1037-1042, 1989.
16. Umayahara, Y., Kawamori, R., Watada, H., Imano, E., Iwama, N., Morishima, T., Yamasaki, Y., Kajimoto, Y., and Kamada, T. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem., 269: 16433-16442, 1994.
17. Weisz, A., and Bresciani, F. Estrogen regulation of proto-oncogenes coding for nuclear proteins. Crit. Rev. Oncog., 4: 361-388, 1993.
18. Piechaczyk, M., and Blanchard, J. c-fos protooncogene regulation and function. Crit. Rev. Oncol. Hematol., 17: 93-131, 1994.
19. Howell, A., Dodwell, D., Anderson, H., and Redford, J. Response after withdrawal of tamoxifen and progestogens in advanced breast cancer. Ann. Oncol., 3: 611-617, 1992.
20. Howell, A., Defriend, D., Robertson, J., Blarney, R., and Walton, P. Response to a specific antioestrogen (ICI182780) in tamoxifen resistant breast cancer. Lancet, 345: 29-30, 1995.